Preliminary clinical trials with praziquantel in Schistosoma japonicum infections in the Philippines

Praziquantel, a new antischistosomal compound, was tested for tolerance and efficacy against placebo in two double-blind clinical trials in Philippine patients infected with Schistosoma japonicum. The compound was given orally at a dose of 3 × 20 mg/kg at intervals of 4 hours to a total of 82 patien...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Santos, A. T., Blas, B. L., Noseñas, J. S., Portillo, G. P., Ortega, O. M., Hayashi, M., Boehme, K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 1979
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395875/
https://ncbi.nlm.nih.gov/pubmed/396056
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky